Trial intelligence / Profile preview

Double-dose vs standard-dose hepatitis B vaccination in adults with HIV (CD4 ≥500)

TCTR20260510007Phase 4Enrolling by invitation

Sponsor
Faculty of Medicine, Chiang Mai University
Start
Apr 2026
Modality
Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of Hepatitis B vaccine in hepatitis B (HBV), sponsored by Faculty of Medicine, Chiang Mai University. Started Apr 2026; status: enrolling by invitation.

02

Drugs

Hepatitis B vaccine
03

Conditions

hepatitis B (HBV)

Beyond the preview

Go deeper on TCTR20260510007.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20260510007.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call